Jason Davies MD, PhD

Jason Davies MD, PhD

Expected Graduation Date: 2015




Education, Training, and Previous Positions

2001: BS, Stanford University
2003-2006: Co-founder, Chief Scientific Officer, Certus Medical
2006-2008: Director, Investor Relations, PaientCentral Technologies
2008: Stanford Graduate School of Business, Institute for Entrepreneurship
2008-Present: Co-founder, S.O.S. Technologies
2009: MD, Stanford School of Medicine, Medical Scientist Training Program
2009: PhD, Program in Biophysics, Stanford School of Medicine, Medical Scientist Training Program

Selected Honors and Awards

2009: Invited Presenter, 8th Annual CyberKnife Users’ Meeting, Hollywood, FL
2009: Best Abstract, 8th Annual CyberKnife Users’ Meeting, Hollywood, FL
2004: Invited Presenter, Molecular & Cell Biology Department, Berkeley, CA
2004: First place, Stanford Medical Student Research Symposium
2003: Invited Presenter, International Meeting on AAA Proteins, Warrenton, VA
2002-2009: Medical Scientist Training Fellowship from NIGMS grant
2001: First place, Biological Sciences Individual Research symposium
1996: Phi Beta Kappa Scholarship
1996: Jesse H. Jones Foundation Scholarship

Selected Recent Publications

Davies JM, Yanamadala V, Lawton MT. Comparative effectiveness of treatments for cerebral arteriovenous malformations: trends in nationwide outcomes from 2000 to 2009. Neurosurg Focus 2012;33(1):E11.

Davies J, Tawk RG, Lawton MT. The contralateral transcingulate approach: operative technique and results with vascular lesions. Neurosurgery 2012;71(1 Suppl Operative):4-13; discussion 13-4.

Davies JM, Kim H, Young WL, Lawton MT. Classification schemes for arteriovenous malformations. Neurosurg Clin N Am 2012;23(1):43-53.

Davies JM, Brunger AT, Weis WI. Improved structures of full-length p97, an AAA ATPase: implications for mechanisms of nucleotide-dependent conformational change. Structure 2008;16(5):715-726.

Nagar B, Hantschel O, Seeliger M, Davies JM, Weis WI, Superti-Furga G, Kuriyan J. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase. Mol Cell 2006;21(6):787-798.

Davies JM, Tsuruta H, May AP, Weis WI. Conformational changes of p97 during nucleotide hydrolysis determined by small-angle X-Ray scattering. Structure 2005;13(2):183-95.

Feinberg H, Uitdehaag JC, Davies JM, Wallis R, Drickamer K, Weis WI. Crystal structure of the CUB1-EGF-CUB2 region of mannose-binding protein associated serine protease-2. EMBO J 2003;22(10):2348-2359.

Prekeris R, Davies JM, Scheller RH. Identification of a novel Rab11/25 binding domain present in Eferin and Rip proteins. J Biol Chem 2001;276(42):38966-38970.